Activity of topotecan given intravenously for 5 days every three weeks in patients with advanced non-small cell lung cancer pretreated with platinum and taxanes: A phase II study

  1. Gonzalez, E.E.
  2. Villanueva, N.
  3. Fra, J.
  4. Berros, J.P.
  5. Jimenez, P.
  6. Luque, M.
  7. Muñiz, I.
  8. Blay, P.
  9. Fernandez, Y.
  10. Vieitez, J.M.
  11. Muriel, C.
  12. Sanmamed, M.
  13. Coto, P.P.
  14. Izquierdo, M.
  15. Estrada, E.
  16. Lacave, A.J.
Revue:
Investigational New Drugs

ISSN: 0167-6997 1573-0646

Année de publication: 2011

Volumen: 29

Número: 6

Pages: 1459-1464

Type: Article

DOI: 10.1007/S10637-010-9442-2 GOOGLE SCHOLAR

Objectifs de Développement Durable